- Home
- BGY vs CRMD Comparison
BGY vs CRMD Comparison
Compare BGY & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BGY | CRMD |
|---|---|---|
| Founded | 2007 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 515.6M | 509.9M |
| IPO Year | N/A | 2009 |
Fundamental Metrics
Financial Performance| Metric | BGY | CRMD |
|---|---|---|
| Price | $5.55 | $6.36 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $14.67 |
| AVG Volume (30 Days) | 322.5K | ★ 1.4M |
| Earning Date | 01-01-0001 | 03-05-2026 |
| Dividend Yield | ★ 7.41% | N/A |
| EPS Growth | N/A | ★ 780.00 |
| EPS | N/A | ★ 2.04 |
| Revenue | N/A | ★ $311,709,000.00 |
| Revenue This Year | N/A | $1.10 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $3.12 |
| Revenue Growth | N/A | ★ 617.03 |
| 52 Week Low | $4.67 | $5.60 |
| 52 Week High | $6.23 | $17.43 |
Technical Indicators
Market Signals| Indicator | BGY | CRMD |
|---|---|---|
| Relative Strength Index (RSI) | 28.64 | 37.00 |
| Support Level | N/A | $6.13 |
| Resistance Level | $5.87 | $7.44 |
| Average True Range (ATR) | 0.10 | 0.29 |
| MACD | -0.04 | 0.02 |
| Stochastic Oscillator | 5.56 | 22.37 |
Price Performance
Historical ComparisonAbout BGY Blackrock Enhanced International Dividend Trust
Blackrock Enhanced International Dividend Trust is a diversified closed-end management investment company. Its primary investment objective is to provide current income and current gains, with a secondary objective of long-term capital appreciation. The Trust invests the majority of its net assets in dividend-paying equity securities issued by non-U.S. companies of any market capitalization, with a key focus on securities of large capitalization companies. It invests directly in such securities or synthetically through the use of derivatives.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.